| Indicators | Browse All

Oaktree Acquisition Corp. III Life Sciences (OACCW)

Los Angeles, United States | NasdaqGM
1.00 USD +0.25 (33.333%) ⇧ (Oct. 13, 2026, 3:45 p.m. EDT)

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 5:34 a.m. EDT

This security is a distressed special purpose acquisition company (SPAC) with a negative book value of $0.31 per share, indicating the company's assets are worth less than its liabilities. The negative operating cash flow of nearly half a million dollars and a current ratio below 0.75 signal severe liquidity constraints and operational distress. With no dividend history, no analyst recommendations, and insufficient price history to assess any momentum or long-term trajectory, there is no economic case for holding this instrument. The negative price-to-book ratio confirms that the market has already priced in a total loss of equity value.

None

Info Dump

Attribute Value
Address1 333 South Grand Avenue
Address2 28th Floor
Ask 0.5601
Ask Size 8
Bid 0.88
Bid Size 1
Book Value -0.305
City Los Angeles
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.0
Current Ratio 0.728
Custom Price Alert Confidence HIGH
Day High 1.0
Day Low 0.8
Earnings Growth -0.144
Earnings Quarterly Growth -0.144
Ebitda Margins 0.0
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Two Week High 1.0
Fifty Two Week High Change 0.0
Fifty Two Week High Change Percent 0.0
Fifty Two Week Low 0.8
Fifty Two Week Low Change 0.19999999
Fifty Two Week Low Change Percent 0.24999999
Fifty Two Week Range 0.8 - 1.0
Financial Currency USD
First Trade Date Milliseconds 1,784,295,000,000
Float Shares 18,458,955
Full Exchange Name NasdaqGM
Fullday Change 0.18
Fullday Change Percent 21.95122
Fullday Price 1.0
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Industry
Industry Key
Ipo Expected Date 2,024-12-16
Language en-US
Long Business Summary Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Long Name Oaktree Acquisition Corp. III Life Sciences
Market us_market
Market State POST
Max Age 86,400
Message Board Id finmb_1890819822
Net Income To Common 6,754,432
Open 0.99
Operating Cashflow -455,689
Operating Margins 0.0
Phone 213 830 6300
Previous Close 0.75
Price Hint 4
Price To Book -3.2786884
Profit Margins 0.0
Quick Ratio 0.682
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.25
Regular Market Change Percent 33.333336
Regular Market Day High 1.0
Regular Market Day Low 0.8
Regular Market Day Range 0.8 - 1.0
Regular Market Open 0.99
Regular Market Previous Close 0.75
Regular Market Price 1.0
Regular Market Time 1,791,920,726
Regular Market Volume 1,157
Sand P52 Week Change 0.17502642
Sector
Sector Key
Short Name Oaktree Acquisition Corp. III L
Source Interval 15
State CA
Symbol OACCW
Total Cash 1,179,670
Total Cash Per Share 0.048
Total Debt 11,824
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Peg Ratio None
Triggerable 1
Type Disp Equity
Volume 1,157
Website https://www.oaktreeacquisitioncorp.com/oac-iii
Zip 90,071